Scancell announces UK authorisation for Phase 3 melanoma trial

Initiator Pharma secures two European patents for pudafensine

Resivant Medical reports first patient cases with Cutiva PLUS Skin Closure System

Andelyn Biosciences to develop and manufacture gene therapy AAV9-GM2 for Queen's University to treat GM2 gangliosidoses

Piramal Pharma acquires controlling stake in Yapan Bio

Curavit acquires Lindus Health CRO assets

Hansa Biopharma reports first Australian transplant using Idefirix

WuXi XDC's Singapore site BCM3 facility achieves GMP release

Slingshot Bio introduces ViaComp Ultra Amine

Leal Therapeutics announces USD30m Series A extension and initiates Phase 1b/2a clinical trial of LTX-001 in schizophrenia

Can-Fite reports preclinical data supporting Phase IIb pancreatic cancer study

Acurx receives FDA conditional acceptance for ibezapolstat brand name

AstraZeneca reports positive Phase III results for Tagrisso and Orpathys

OmniAb signs global ion channel collaboration with Eli Lilly

HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination